OMTX-705 is under clinical development by Oncomatryx Biopharma and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I drugs for Gastric Cancer have a 74% phase transition ...

OMTX-705 is under clinical development by Oncomatryx Biopharma and currently in Phase I for Leiomyosarcoma. According to GlobalData, Phase I drugs for Leiomyosarcoma have a 92% phase transition ...

How to Implement an Effective Cleanroom Monitoring System In light of these potential problems, biopharma companies should ...

The BD+C editorial team asked the 2024 Architecture Giants to submit their single-biggest firm innovation or business move ...

INR:4690. football jersey design with shorts Eli Lilly's innovative combination therapy for lung cancer is approved in Europe, Gilead promotes ...

Data is the “business of lifeblood” as specialist firms like TetraScience work to accelerate scientific AI by designing and industrializing AI-native scientific datasets.

Fintel reports that on December 24, 2024, LifeSci Capital initiated coverage of Mereo BioPharma Group plc - Depositary ...

double bed design The overseas rights of Aisen Biopharma's third-generation EGFR-TKI "Avitinib" were sold after failing to obtain the first domestically produced Innovative therapy targeting dual ...

FORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...